Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension
- PMID: 2804022
- PMCID: PMC1041860
- DOI: 10.1136/bjo.73.9.693
Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension
Abstract
Forty-three patients with glaucoma and 24 patients with ocular hypertension presenting with a retinal vein occlusion were medically assessed. The prevalence of systemic hypertension was 60.5% in those with glaucoma and 66.6% with ocular hypertension. The prevalence of hyperlipidaemia was 38.1% in those with glaucoma and 37.5% in those with ocular hypertension. These findings were compared with those from a carefully age-sex matched group of patients presenting with a retinal vein occlusion without evidence of glaucoma or ocular hypertension. There were no statistical differences between any of the groups (52.2% had systemic hypertension and 28.8% had hyperlipidaemia). There was also a strikingly high prevalence of systemic hypertension (89%) and hyperlipidaemia (55.5%) in nine of the patients who had evidence of a recurrent retinal vein occlusion associated with glaucoma, and these prevalence rates were strikingly similar to the rates in patients with recurrence but without glaucoma. The data suggest that glaucoma or ocular hypertension has a less prominent aetiological role in the development of a retinal vein occlusion than underlying medical causes and that full medical assessment is worthwhile.
Comment in
-
Retinal vein occlusion and glaucoma.Br J Ophthalmol. 1989 Sep;73(9):690-1. doi: 10.1136/bjo.73.9.690. Br J Ophthalmol. 1989. PMID: 2804020 Free PMC article. No abstract available.
Similar articles
-
Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):725-732. doi: 10.1007/s00417-016-3553-1. Epub 2016 Nov 22. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27878430
-
Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University.Ophthalmologica. 1997;211(5):288-91. doi: 10.1159/000310810. Ophthalmologica. 1997. PMID: 9286803
-
Retinal vascular events after intravitreal bevacizumab.Acta Ophthalmol. 2010 Nov;88(7):730-5. doi: 10.1111/j.1755-3768.2009.01535.x. Acta Ophthalmol. 2010. PMID: 20039854
-
[Risk factors in central retinal vein occlusion].Oftalmologia. 2011;55(2):27-37. Oftalmologia. 2011. PMID: 21888066 Review. Romanian.
-
[Ocular hypertonia disclosed by the association of central retinal vein and cilioretinal artery occlusions].Bull Soc Ophtalmol Fr. 1990 May;90(5):521-4. Bull Soc Ophtalmol Fr. 1990. PMID: 2208518 Review. French. No abstract available.
Cited by
-
Central retinal vein occlusion: what's the story?Br J Ophthalmol. 1997 Aug;81(8):698-704. doi: 10.1136/bjo.81.8.698. Br J Ophthalmol. 1997. PMID: 9349161 Free PMC article. Review. No abstract available.
-
Paget's disease and angioid streaks: one complication less?Br J Ophthalmol. 1990 Oct;74(10):577-8. doi: 10.1136/bjo.74.10.577. Br J Ophthalmol. 1990. PMID: 2285678 Free PMC article. No abstract available.
-
Pseudoexfoliation and glaucoma in eyes with retinal vein occlusion.Int Ophthalmol. 1999;23(2):75-8. doi: 10.1023/a:1026557029227. Int Ophthalmol. 1999. PMID: 11196123 Clinical Trial.
-
Retinal vein occlusions: a review for the internist.Intern Emerg Med. 2011 Aug;6(4):307-14. doi: 10.1007/s11739-010-0478-2. Epub 2010 Dec 14. Intern Emerg Med. 2011. PMID: 21547483 Review.
-
Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.Front Med (Lausanne). 2022 Jun 15;9:910600. doi: 10.3389/fmed.2022.910600. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35783660 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical